ArticleOncotarget2016
ATG9A loss confers resistance to trastuzumab via c-Cbl mediated Her2 degradation.
Joao Nunes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it
ArticleOncotarget2016
Joao Nunes et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.